Immunohistochemistry Market

Immunohistochemistry Market by Products (Antibodies [Primary Antibodies and Secondary Antibodies], Equipment [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others], Reagents [Histological Stains, Blocking sera & Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents], and Kits), Applications (Diagnostics [Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Nephrological Diseases] and Drug Testing), End-users (Hospitals & Diagnostic Laboratories, Research Institutes, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028

  • Report ID: HC-872
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 159
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global immunohistochemistry market size was valued at USD 1.81 billion in 2020 and is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to technologically advanced immunohistochemistry solutions, increasing drug discovery and development activities, and rising prevalence of chronic diseases.

Immunohistochemistry Market-Key Takeaways

Immunohistochemistry (IHC), a critical application of monoclonal and polyclonal antibodies, aids in the study of an antigen's tissue distribution. It is utilized to find enzymes, tumor suppressor genes, antigens, and the proliferation of tumor cells. IHC is a technique that uses the concept of antibodies attaching selectively to antigens in biological tissues to detect antigens or haptens in cells of a tissue segment. IHC has become an important diagnostic tool for a variety of chronic disorders including cancer, infectious disorders, and cardiovascular diseases (CVDs). As a result of the increase in the incidence of these chronic diseases, the need for IHC techniques has increased. IHC is also an important technique in the development of biomarkers, hence the market has been growing in line with the rising need for biomarkers. Various immunohistochemistry equipment, such as slide staining systems, tissue microarrays (TMA), tissue processing systems, slide scanners, and other equipment, are utilized in the diagnostic and drug testing procedure.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing incidence of cancer and other chronic diseases around the world present a key driver for the market expansion.
  • Growing governments’ focus and implementation of policies in medical and healthcare investment as well as the rising shift to value-based healthcare solutions are all contributing to the global market growth.
  • Rapid adoption of advanced technologies in the medical and healthcare industries and massive investment in the development of innovative technique are expected to fuel this market.
  • Lack of number of skill-technical staff and high setup cost of the equipment associated with IHC techniques are projected to restrain the market expansion.
  • Ongoing R&D and extensive laboratory research in related to drug discovery and other diagnostic experiments are anticipated to offer lucrative opportunities for the market growth.

Scope of the Report

The report on the global immunohistochemistry market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Immunohistochemistry Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Antibodies [Primary Antibodies, Secondary Antibodies], Equipment [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others], Reagents [Histological Stains, Blocking Sera & Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents], and Kits), Applications (Diagnostics [Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Nephrological Diseases] and Drug Testing), and End-users (Hospitals & Diagnostic Laboratories, Research Institutes, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abcam plc; Agilent Technologies; Bio SB; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.


Global Immunohistochemistry Market Segment Insights

Antibodies segment to account for a key market share
Based on products, the global immunohistochemistry market is segmented into antibodies, equipment, reagents, and kits. The antibodies segment is further divided into primary antibodies, secondary antibodies. The equipment segment consists of slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others. Meanwhile, the reagents segment includes histological stains, blocking sera & reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents. The antibodies segment is expected to account for a key share of the market in the coming years owing to the continuous usage in IHC procedures for disease diagnosis and drug testing. Therapeutic monoclonal antibodies and antibody-related products such as antibody fragments, Fc-fusion proteins, and antibody-drug conjugates are major product categories to become the market's leading product class. The primary antibodies segment dominated the immunohistochemistry market as these products are mainly used in the diagnosis of chronic diseases at a large extent.

The kits segment, on the other hand, is anticipated to grow significantly during the forecast period due to their compact nature and convenience. IHC kits are widely used in research laboratories and academic institutions that need limited quantities of these items for conducting research, as opposed to other end-use settings that require large quantities.

Diagnostics segment to hold a large share
On the basis of applications, the market is bifurcated into drug testing and diagnostics. The diagnostic segment is further segmented into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases. The diagnostics segment is expected to expand significantly during the forecast period due to its wide prevalence of chronic diseases. Moreover, growing number of R&D activities by key pharmaceutical companies and wide adoption of advanced technology for the discovery and production of novel drugs are expected to boost demand for IHC solutions and support the segmental growth.

Immunohistochemistry Market-By Applications

Hospitals & diagnostic laboratories to constitute a key market share
Based on end-users, the global immunohistochemistry market is segmented into research institutes, hospitals & diagnostic laboratories, and others. The Hospitals and diagnostic laboratories segment is projected to constitute a key market share during the forecast period owing to increase in the demand for disease diagnosis, impacted by the rise in the incidence of chronic diseases. Furthermore, the advancement in technology such as automated sample preparation and digital pathology have added significant value of the segment. Additionally, the growing number of hospitals and clinical research laboratories are key drivers boosting the demand for diagnostics, propelling the segment growth.

Meanwhile, the research institutes segment is anticipated to grow significantly during the forecast period due to the increasing adoption of IHC solutions in research institutes for drug discovery and development activities. The other end-users segment includes contract research organizations (CROs) and forensic laboratories. The growing trend of pharmaceutical and biotech companies involved in the outsourcing drug development activities is expected to boost the CROs segment's growth.

North America to register a substantial growth
In terms of regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to register a substantial growth rate in terms of revenue share during the forecast period. The regional growth market is attributed to well-established healthcare infrastructure, which has led to an increase in the adoption of IHC instruments in laboratories and diagnostic centers. The favorable reimbursement framework in this region presents a key factor boosting the market penetration of automated immunohistochemistry instruments. The increasing incidence of cancer in the region is another factor for the market growth in the region.

The market in Asia Pacific, however, is expected to grow significantly during the forecast period due to rapid economic development in countries such as China, India, South Korea, and Singapore. Furthermore, the rapidly aging population and the high prevalence of chronic diseases are expected to be major drivers of the immunohistochemistry market in the region.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunohistochemistry Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Immunohistochemistry Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Immunohistochemistry Market - Supply Chain
  4.5. Global Immunohistochemistry Market Forecast
     4.5.1. Immunohistochemistry Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Immunohistochemistry Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Immunohistochemistry Market Absolute $ Opportunity
5. Global Immunohistochemistry Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Immunohistochemistry Market Size and Volume Forecast by End Users
     5.3.1. Hospitals & Diagnostic Laboratories
     5.3.2. Research Institutes
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Immunohistochemistry Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Immunohistochemistry Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Immunohistochemistry Demand Share Forecast, 2019-2026
7. North America Immunohistochemistry Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Immunohistochemistry Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Immunohistochemistry Market Size and Volume Forecast by End Users
     7.4.1. Hospitals & Diagnostic Laboratories
     7.4.2. Research Institutes
     7.4.3. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Immunohistochemistry Demand Share Forecast, 2019-2026
8. Latin America Immunohistochemistry Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Immunohistochemistry Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Immunohistochemistry Market Size and Volume Forecast by End Users
     8.4.1. Hospitals & Diagnostic Laboratories
     8.4.2. Research Institutes
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Immunohistochemistry Demand Share Forecast, 2019-2026
9. Europe Immunohistochemistry Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Immunohistochemistry Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Immunohistochemistry Market Size and Volume Forecast by End Users
     9.4.1. Hospitals & Diagnostic Laboratories
     9.4.2. Research Institutes
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Immunohistochemistry Demand Share Forecast, 2019-2026
10. Asia Pacific Immunohistochemistry Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Immunohistochemistry Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Immunohistochemistry Market Size and Volume Forecast by End Users
     10.4.1. Hospitals & Diagnostic Laboratories
     10.4.2. Research Institutes
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Immunohistochemistry Demand Share Forecast, 2019-2026
11. Middle East & Africa Immunohistochemistry Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Immunohistochemistry Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Immunohistochemistry Market Size and Volume Forecast by End Users
     11.4.1. Hospitals & Diagnostic Laboratories
     11.4.2. Research Institutes
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Immunohistochemistry Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Immunohistochemistry Market: Market Share Analysis
  12.2. Immunohistochemistry Distributors and Customers
  12.3. Immunohistochemistry Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Abcam plc
     12.4.2. Agilent Technologies
     12.4.3. Bio SB
     12.4.4. Bio-Rad Laboratories, Inc.
     12.4.5. Cell Signaling Technology, Inc.
     12.4.6. Danaher Corporation
     12.4.7. F. Hoffmann-La Roche AG
     12.4.8. Merck KGaA
     12.4.9. PerkinElmer, Inc.
     12.4.10. Thermo Fisher Scientific, Inc.
Segments Covered in the Report
The global immunohistochemistry market has been segmented on the basis of

Products
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking Sera & Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits
Application
  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing
End-users
  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abcam plc
  • Agilent Technologies
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

Some of the major players competing in the immunohistochemistry market are Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd.; Merck KGaA; Danaher Corporation; Perkinelmer, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Bio SB; Agilent Technologies, Inc.; and Abcam plc.

To improve their market position and gain a significant market share, these major players are constantly focusing to implement organic growth strategies such as product creation and upgradation. For example, Danaher Corporation's subsidiary, Leica Biosystems launched an updated version of its BOND-III IHC and ISH stainer in March 2018 with an aim to offer ease-of-use of both the instrument hardware and software. Similarly, PerkinElmer announced the release of Vectra Polaris, an Automated Quantitative Pathology Imaging System, in January 2017, which was intended to help researchers gain a better understanding of cancer immunotherapy strategies.

 Immunohistochemistry Market-By Key Players

Buy Report